Latest Breaking News On - Net product revenue - Page 1 : comparemela.com

Karyopharm Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress

Karyopharm Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

South koreaKyongsang buktoUnited kingdomUnited statesRichard paulsonDrug administrationPrnewswire karyopharm therapeutics incExchange commissionInformation departmentKaryopharm therapeutics incNational institute for healthMainland china national reimbursement drug listKaryopharm selective inhibitor of nuclear exportCompany three phaseMenarini groupAnnounces significant refinancing transactions

Karyopharm Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company Progress

Karyopharm Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company Progress
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomKyongsang buktoSouth koreaSoult ukpyolsiHong kongBristol myers squibbRichard paulsonSelective inhibitor of nuclear exportCompany providesInformation departmentExchange commissionAmerican society of hematologyInternational gynecological cancer society annual global meetingTrademark officePrnewswire karyopharm therapeutics inc

Ocular Therapeutix™ Provides Third Quarter 2023 Financial Results and Corporate Update

Ocular Therapeutix™ Provides Third Quarter 2023 Financial Results and Corporate Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Investorsocular therapeutixdonald notmanchiefMediaicr westwickeben shannonAntony mattessichCenters for medicareInc condensed consolidated statements of operationsDrug administrationExchange commissionOcular therapeutix incMedicaid servicesOverall designFirst pivotal trialSpecial protocol assessmentExpect first subject dosedPrimary open angle glaucomaOcular hypertension anticipatedEarly april

Fennec Pharmaceuticals Announces Third Quarter 2023 Financial Results and Provides Business Update

~ PEDMARK® Net Product Revenue of $6.5 Million, a 96% Increase Compared to Second Quarter ~ ~ Strong Commercial Uptake Underscoring Significant Unmet Medical Need ~ ~ Received Approval in October.

United statesRosty raykovRobert andradeLindsay roccoLandierw ototoxicityOregon healthCompany in europeEuropean commission marketing authorizationDrug administrationChildren oncology groupScience universityHealthcare products regulatory agencyClinical oncology groupExchange commissionElixir health public relationsFennec pharmaceuticals inc

Karyopharm Reports Third Quarter 2023 Financial Results and Highlights Recent Company Progress

Karyopharm Reports Third Quarter 2023 Financial Results and Highlights Recent Company Progress
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomSouth koreaKyongsang buktoBristol myers squibbRichard paulsonExchange commissionMenarini groupNational comprehensive cancer networkInformation departmentEuropean gynaecological oncology congressInternational conference on molecularSelective inhibitor of nuclear exportKaryopharm selective inhibitor of nuclear exportPrnewswire karyopharm therapeutics incKaryopharm therapeutics inc